Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide added to standard triple therapy for Helicobacter pylori eradication
PACTR202112686695509Phase 4Not yet recruiting
- Sponsor
- No
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nitazoxanide, amoxicillin and metronidazole in Helicobacter pylori infection (4 arms), sponsored by No. Primary endpoint: Helicobacter pylori eradication rate. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
nitazoxanideamoxicillinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202112686695509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202112686695509.